levodopa has been researched along with Lewy Body Disease in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 24 (51.06) | 29.6817 |
| 2010's | 18 (38.30) | 24.3611 |
| 2020's | 5 (10.64) | 2.80 |
| Authors | Studies |
|---|---|
| MacDonald, S; Shah, AS; Tousi, B | 1 |
| Djoukhadar, I; Jabbari, E; Kobylecki, C; Lally, I; Leahy, CB; Morris, HR; Robinson, AC; Roncaroli, F | 1 |
| Asghar, M; Fattahi, AJ; Henriksson, AE; Khosousi, S; Miglar, A; Odeh, A; Svenningsson, P | 1 |
| Ikeda, M; Konishi, O; Mori, E; Orimo, S; Yamada, T | 1 |
| Imbimbo, BP; Lozupone, M; Panza, F; Watling, M | 1 |
| Hershey, LA; Irwin, DJ | 1 |
| Hasegawa, K; Iiyama, S; Kosaka, K; Murata, M; Nakamura, M; Odawara, T; Tagawa, M | 1 |
| Coleman-Jackson, R; Hershey, LA | 1 |
| Konishi, O; Manabe, Y; Odawara, T | 1 |
| Archie, A; Persoons, P; Vandenbulcke, M | 1 |
| Fujishiro, H; Kasanuki, K; Nakamura, S | 1 |
| Barrou, Z; Boddaert, J; Dieudonné, B; Faucounau, V; Greffard, S; Habert, MO; Verny, M | 1 |
| Kaur, M; Kushwaha, S; Malhotra, HS; Panda, AK | 1 |
| Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S | 1 |
| Brandabur, M; Goetz, CG; Goldman, JG; Sanfilippo, M; Stebbins, GT | 1 |
| Aarsland, D; Ballard, CG; Ehrt, U; Francis, PT; Larsen, JP; Perry, EK; Perry, RH; Piggott, MA; Sharp, SI; Ziabreva, I | 1 |
| Boecker, H; Ceballos-Baumann, AO; Drzezga, A; Förstl, H; Granert, O; Häussermann, P; Kurz, A; Perneczky, R | 1 |
| Burn, DJ; McKeith, IG; Minett, T; Molloy, S; O'Brien, JT | 1 |
| McKeith, I | 1 |
| Heinz, A; Majic, T; Mell, T; Rapp, MA | 1 |
| Baldacci, F; Berti, C; Bonuccelli, U; Ceravolo, R; Del Dotto, P; Dolciotti, C; Gambaccini, G; Logi, C; Lucetti, C; Rossi, G | 1 |
| Tison, F | 1 |
| Aarsland, D; Engedal, K; Larsson, V; Londos, E; Minthon, L; Wattmo, C | 1 |
| Ohki, M; Tayama, N | 1 |
| Gomperts, SN; Growdon, JH; Johnson, KA; Locascio, JJ; Marquie, M; Maye, J; Rentz, DM; Santarlasci, AL | 1 |
| Wurtman, RJ | 1 |
| Antonini, A; Bonanni, L; Onofrj, M; Perfetti, B; Petrucci, S; Stocchi, F; Taylor, JP; Thomas, A; Valente, EM; Varanese, S | 1 |
| Sulkava, R | 1 |
| Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE | 1 |
| Rajput, A; Rajput, AH; Robinson, CA | 1 |
| Finley, R; Lee, KC; Miller, B | 1 |
| Bonelli, SB; Deibl, M; Lampl, C; Lukas, T; Ransmayr, G; Steffelbauer, M | 1 |
| Burn, DJ; Firbank, MJ; McKeith, IG; O'Brien, JT | 1 |
| Driguès, N; Sagi, Y; Youdim, MB | 1 |
| Burn, DJ; McKeith, IG; Molloy, S; O'Brien, JT | 1 |
| Le Rhun, E; Lebert, F | 1 |
| Burn, DJ; McKeith, IG; Molloy, SA; O'Brien, JT; Rowan, EN; Wesnes, K | 1 |
| Damier, P; Meyniel, C | 1 |
| Bancher, C; Dal-Bianco, P; Jellinger, K; Katzenschlager, R; Poewe, W; Ransmayr, G; Schmidt, R; Wenning, G | 1 |
| Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M | 1 |
| Jellinger, K; Poewe, W; Ransmayr, G; Seppi, K; Wenning, GK | 1 |
| Masson, C | 1 |
| Ballard, C; Campbell, S; Stephens, S | 1 |
| Ahlskog, JE; Apaydin, H; Boeve, BF; Dickson, DW; Parisi, JE | 1 |
| Kato, K; Kawakatsu, S; Otani, K; Wada, T | 1 |
| Burke, MA; Fernandez, HH; Friedman, JH; Trieschmann, ME | 1 |
9 review(s) available for levodopa and Lewy Body Disease
| Article | Year |
|---|---|
Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
Topics: Dementia; Drug Development; Humans; Levodopa; Lewy Body Disease; Parkinson Disease | 2022 |
Pharmacological Management of Dementia with Lewy Bodies.
Topics: Age Factors; Aged; Anticonvulsants; Antiparkinson Agents; Cholinesterase Inhibitors; Clinical Trials, Phase II as Topic; Clonazepam; Humans; Levodopa; Lewy Body Disease; Melatonin; Randomized Controlled Trials as Topic; Zonisamide | 2019 |
["Red flags": when to be alerted and how to explore?].
Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive | 2010 |
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies.
Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease | 2003 |
[Treatment of dementia with Lewy bodies].
Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy | 2006 |
[Lewy body dementia and Parkinson disease dementia].
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists | 2007 |
[Dementia with Lewy bodies].
Topics: Aged; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Diagnostic Imaging; Female; Humans; Levodopa; Lewy Body Disease; Male | 2000 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
Dementia with Lewy bodies: clinical features and treatment.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Middle Aged; Motor Activity | 2001 |
9 trial(s) available for levodopa and Lewy Body Disease
| Article | Year |
|---|---|
Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study.
Topics: Humans; Levodopa; Lewy Body Disease; Zonisamide | 2023 |
Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Zonisamide | 2018 |
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
Topics: Aged; Dopamine Agonists; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Mental Disorders; Movement Disorders | 2008 |
Levodopa use and sleep in patients with dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires; Time Factors | 2009 |
Levodopa response in dementia with lewy bodies: a 1-year follow-up study.
Topics: Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease | 2010 |
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Levodopa; Lewy Body Disease; Male; Memantine; Neuropsychological Tests; Parkinson Disease; Quality of Life; Treatment Outcome | 2011 |
The role of levodopa in the management of dementia with Lewy bodies.
Topics: Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Female; Humans; Levodopa; Lewy Body Disease; Male; Mental Status Schedule; Severity of Illness Index; Treatment Outcome | 2005 |
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Female; Humans; Levodopa; Lewy Body Disease; Male; Motor Skills; Parkinson Disease; Treatment Outcome | 2006 |
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
Topics: Aged; Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Lewy Body Disease; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2002 |
29 other study(ies) available for levodopa and Lewy Body Disease
| Article | Year |
|---|---|
A case of Lewy body disease and anaplastic astrocytoma presenting with atypical parkinsonism.
Topics: Humans; Levodopa; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders | 2022 |
Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia.
Topics: Cellular Senescence; Dementia; DNA, Mitochondrial; Humans; Levodopa; Lewy Body Disease; Organelle Biogenesis; Parkinson Disease; Telomere | 2022 |
Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism.
Topics: Brain; Europe; Humans; Levodopa; Lewy Body Disease; Zonisamide | 2021 |
Zonisamide for DLB parkinsonism: An old drug used in a new context.
Topics: Double-Blind Method; Humans; Levodopa; Lewy Body Disease; Parkinsonian Disorders; Zonisamide | 2018 |
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor | 2019 |
[The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia].
Topics: Aged; Antipsychotic Agents; Brain; Clozapine; Comorbidity; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Treatment Outcome | 2013 |
Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.
Topics: Affect; Aged; Comorbidity; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Treatment Outcome | 2013 |
Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dopamine Plasma Membrane Transport Proteins; Female; Geriatric Assessment; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2014 |
Serotonin syndrome following levodopa treatment in diffuse Lewy body disease.
Topics: Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Serotonin Syndrome | 2014 |
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases | 2016 |
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Autopsy; Cerebral Cortex; Dementia; Depression; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Temporal Lobe | 2008 |
Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Brain Chemistry; Cognition; Data Interpretation, Statistical; Dementia; Education; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2008 |
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments.
Topics: Antiparkinson Agents; Clozapine; Delusions; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Severity of Illness Index | 2010 |
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Severity of Illness Index | 2010 |
Dysphagia due to isoniazid therapy for tuberculosis in a patient with Lewy body dementia.
Topics: Aged; Antitubercular Agents; Deglutition Disorders; Dopamine Agents; Drug Interactions; Endoscopy; Female; Fluoroscopy; Humans; Isoniazid; Levodopa; Lewy Body Disease; Tuberculosis, Pleural; Video Recording | 2013 |
Brain amyloid and cognition in Lewy body diseases.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Antiparkinson Agents; Apolipoprotein E3; Cognition; Cognitive Dysfunction; Female; Genotype; Humans; Levodopa; Lewy Body Disease; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Thiazoles | 2012 |
Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.
Topics: alpha-Synuclein; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Cognition; Cognition Disorders; Diagnosis, Differential; Diagnostic Imaging; Frontotemporal Dementia; Genetic Markers; Genetic Testing; Glucosylceramidase; Humans; Huntington Disease; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Lewy Body Disease; Mutation; Parkinson Disease; Precision Medicine; Protein Serine-Threonine Kinases | 2013 |
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Double-Blind Method; Female; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Prevalence; Severity of Illness Index; Treatment Outcome; Tremor | 2013 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome | 2003 |
Essential tremor course and disability: A clinicopathologic study of 20 cases.
Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive | 2004 |
Apraxia of lid opening: dose-dependent response to carbidopa-levodopa.
Topics: Aged; Apraxia, Ideomotor; Blepharospasm; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Eyelid Diseases; Eyelids; Female; Humans; Levodopa; Lewy Body Disease; Time Factors | 2004 |
L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia.
Topics: Aged; Aged, 80 and over; Dementia; Dopamine Agonists; Female; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Predictive Value of Tests; Prospective Studies | 2004 |
Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.
Topics: Aged; Antiparkinson Agents; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Lewy Body Disease; Longitudinal Studies; Male; Motor Activity; Parkinson Disease; Psychological Tests; Tomography, Emission-Computed, Single-Photon | 2005 |
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan | 2005 |
[Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
Topics: Alzheimer Disease; Antiparkinson Agents; Antipsychotic Agents; Austria; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Neuropsychological Tests | 2007 |
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals | 2008 |
[Parkinson's disease].
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 2001 |
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Disease Progression; Female; Humans; Incidence; Levodopa; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Parkinson Disease; Plaque, Amyloid; Prevalence; Retrospective Studies | 2002 |
Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Brain; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Risperidone | 2002 |